CDKN2B-AS1 and cancer: ANRIL also participates in the regulation of gene expression via mechanisms including chromatin modulation, TF binding, and miRNA regulation [203,204,205], and can be considered as a driver in cancer progression by increasing glucose uptake for glycolysis, and additionally, ANRIL has also been linked to fatty acid metabolism [206,207].